BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20158689)

  • 1. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.
    Yu MY; Alter HJ; Virata-Theimer ML; Geng Y; Ma L; Schechterly CA; Colvin CA; Luban NL
    Transfusion; 2010 Aug; 50(8):1712-21. PubMed ID: 20158689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Look-back study on recipients of Parvovirus B19 (B19V) DNA-positive blood components.
    Juhl D; Özdemir M; Dreier J; Görg S; Hennig H
    Vox Sang; 2015 Nov; 109(4):305-11. PubMed ID: 26053938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
    Juhl D; Görg S; Hennig H
    Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion.
    Kleinman SH; Glynn SA; Lee TH; Tobler LH; Schlumpf KS; Todd DS; Qiao H; Yu MY; Busch MP;
    Blood; 2009 Oct; 114(17):3677-83. PubMed ID: 19687508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
    Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
    Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil.
    Slavov SN; Gonçalves de Noronha LA; Gonzaga FAC; Pimentel BMS; Kashima S; Haddad R
    J Med Microbiol; 2019 Apr; 68(4):622-626. PubMed ID: 30843782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
    Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
    J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors.
    Lee TH; Kleinman SH; Wen L; Montalvo L; Todd DS; Wright DJ; Tobler LH; Busch MP;
    Transfusion; 2011 Sep; 51(9):1896-908. PubMed ID: 21303368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
    Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
    Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.
    Abdelrahman D; Al-Sadeq DW; Smatti MK; Taleb SA; AbuOdeh RO; Al-Absi ES; Al-Thani AA; Coyle PV; Al-Dewik N; Qahtani AAA; Yassine HM; Nasrallah GK
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
    Jain A; Jain P; Prakash S; Kumar A; Khan DN; Seth A; Gupta S; Kant R
    J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.
    Sun P; Jiang P; Liu Q; Zhang R; Wang Z; Cao H; Ye X; Ji S; Han J; Lu K; He X; Fan J; Cao D; Zhang Y; Yin Y; Chen Y; Zhao X; Ye S; Su N; Du X; Ma L; Li C
    PeerJ; 2023; 11():e15698. PubMed ID: 37554334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
    Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
    J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic study of human parvovirus B19 infection in East China.
    Zhang L; Cai C; Pan F; Hong L; Luo X; Hu S; Xu J; Chen Z
    J Med Virol; 2016 Jul; 88(7):1113-9. PubMed ID: 26705119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic parvovirus B19 infection caused by blood component transfusion.
    Satake M; Hoshi Y; Taira R; Momose SY; Hino S; Tadokoro K
    Transfusion; 2011 Sep; 51(9):1887-95. PubMed ID: 21332725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion.
    Cohen BJ; Beard S; Knowles WA; Ellis JS; Joske D; Goldman JM; Hewitt P; Ward KN
    Transfusion; 1997 Sep; 37(9):947-52. PubMed ID: 9308643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants?
    Molenaar-de Backer MW; Russcher A; Kroes AC; Koppelman MH; Lanfermeijer M; Zaaijer HL
    J Clin Virol; 2016 Nov; 84():19-23. PubMed ID: 27664778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvovirus B19: What Is the Relevance in Transfusion Medicine?
    Juhl D; Hennig H
    Front Med (Lausanne); 2018; 5():4. PubMed ID: 29450198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
    Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall prevalence of human parvovirus B19 among blood donors in mainland China: A PRISMA-compliant meta-analysis.
    Li X; Lin Z; Liu J; Tang Y; Yuan X; Li N; Lin Z; Chen Y; Liu A
    Medicine (Baltimore); 2020 Apr; 99(17):e19832. PubMed ID: 32332630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.